ABSTRACT
in the treatment of diabetes (Rizvi and Mishra, 2013 ). The present review on Ficus racemosa, is aiming to draw attention of the researchers to expand the use of this plant in the ethno-pharmacotherapy and the development of new herbal drugs; as the technology is now extremely more powerful than before.
II. Materials and Methods

Plant description
Ficus racemosa Linn. (Family: Moraceae), which is considered sacred, has golden coloured exudates and black bark (Joy et al., 2001) . This is native to Australia, South-East Asia and the Indian subcontinent. The plant is frequently found around the water streams and is also cultivated (Joseph and Raj, 2010) . It is a large deciduous tree up to 18m high, leaves are ovate, ovate-lanceolate or elliptic, sub-acute, entire and petiolate and are shed usually by December and replenished by January and April, when the tree becomes bare for a short period. It has evergreen leaves; if it is close to a water source (Paarakh, 2009 ). Figs are subglobose or pyriform, red when ripe, borne in large clusters, on short, leafless branches emerging from the trunk and the main branches (Cooke, 1967) . The tree is without aerial roots unlike its many family members (Anita and Mittal, 2011 
Phyto-chemicals and their anti-diabetic roles
All parts of the Ficus racemosa plants possess diverse phyto-chemicals which are enlisted in table 01. Among them, some phyto-chemicals have potent anti-diabetic principle which is given in table 02.
Summary of experimental procedures
Scientists used a number of experimental methods to show the anti-diabetic potentials of Ficus racemosa. These methods are summarized in table 03.
III. Results and Discussion
Physiological (body weight) effects of the extracts
Increased breakdown of glycogen and pronounced gluconeogenesis in diabetes might be responsible for the reduction in body weight of diabetic animals (Sophia and Manoharan, 2007) . Table 04 shows an increase in the body weight in Ficus racemosa plants extracts treated diabetic animals with respect to diabetic control may be due to the protective effect of the extract in controlling muscle wasting, i.e., reversal of gluconeogenesis and may also be due to the improvement in insulin secretion and glycemic control. According to the literature, F. racemosa bark methanolic extract @ 200mg/kgbw showed the best improvement in body weight of experimental animals.
Hypoglycemic effects
Excessive hepatic glycogenolysis and gluconeogenesis associated with decreased utilization of glucose by tissues is the fundamental mechanism underlying hyperglycemia in the diabetic state (Latner, 1958 
Current state, limitations and remedies
Except for the use of F. racemosa plants for local health care needs, not much information has been available on their market potential and trading possibilities. A major factor impeding the development of the medicinal plant based industries and commercial use of these plant extract in developing countries has been the lack of information, systematic data and insufficient in-depth research on the social and economic benefits that could be derived from the industrial utilization of these medicinal plants ( De Silva, 1996) . As a result, the governments or entrepreneurs have not exploited the real potential of these plants. In developing countries, diabetes-specific barriers include lack of patient education about diabetes and diabetes management, stigmatization, too little/weak diagnosis and treatment facilities, negligence, poor training of healthcare professionals (HCPs) and the cost of the anti-diabetic products. Changing diabetes situation in Bangladesh requires partnerships with public and private sectors to strengthen the healthcare system, patient empowerment, access to treatment and advocacy combined with patient-focused investments in the quality of healthcare delivery. Several authors are currently being undertaken to isolate the active compounds by bioassay-guided fractionation from the species that showed high biological activity during screening (Pathak and Das, 2013) . Studies on such plants with respect to their efficacy, safety profile, adverse interaction, proper standardization, etc. need to be conducted with utmost priority not only by the respective manufacturers but also by the pharmacy, pharmacognosy and medicinal enterprises.
Future prospect
Majority of experiments confirmed benefits of F. racemosa in the management of diabetes mellitus. Numerous mechanisms have been proposed for this plant extracts. All of these actions may be responsible for the reduction of diabetic complications (Bnouham et al., 2006) . There occurs a selective decrease in the hyperglycemic state after the administration of extracts of different parts of the plant, which may be mediated through a number of bioactive compounds present in the extract (Khan et al., 2011) . Herbal drugs have increased in popularity due to their natural origin, lesser side effects and low cost. It is recommended that the plant extract of F. racemosa can be successfully utilized in combination for the cure of diabetes and related diseases due to their hypoglycemic action. Polyherbal therapy is said to be a better choice in the treatment of diabetes mellitus having the advantage of producing maximum therapeutic efficacy with minimal side effects. This may provide synergistic, potentiative, agonistic/antagonistic pharmacological properties within themselves because of the presence of vast range of phytobioactive constituents (Raghavendra et al., 2011) . This also gives an opportunity to reduce the dose of herbs used for glycemic control in order to avoid the burden of herbal overdosing. Therefore, such combined therapy might be the key future driving force in the realm of green pharmacology and pharmacognosy (Rawat et al., 2012) .
IV. Conclusion
The plant parts of F. racemosa, which has been used as a crude drug for the welfare of mankind in old civilization, is now of a matter of concern due to its unexplored potentials obtained by various modern techniques. F. racemosa possess compounds that have potential anti-diabetic activities as discussed in the present paper. Such knowledge can be applied in future studies aimed at a safe, evidence-based use of traditional medicinal plants in global phyto-pharmacotherapy and also for the discovery of novel leads for herbal drug development, might be useful for the developing as well as the developed countries.
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